These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 1617803)
1. Determination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: a risk of early osteopaenia in post-menopausal women. Lehmke J; Bogner U; Felsenberg D; Peters H; Schleusener H Clin Endocrinol (Oxf); 1992 May; 36(5):511-7. PubMed ID: 1617803 [TBL] [Abstract][Full Text] [Related]
2. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis? Földes J; Tarján G; Szathmari M; Varga F; Krasznai I; Horvath C Clin Endocrinol (Oxf); 1993 Nov; 39(5):521-7. PubMed ID: 8252739 [TBL] [Abstract][Full Text] [Related]
3. Prospective study of bone loss in pre- and post-menopausal women on L-thyroxine therapy for non-toxic goitre. De Rosa G; Testa A; Giacomini D; Carrozza C; Astazi P; Caradonna P Clin Endocrinol (Oxf); 1997 Nov; 47(5):529-35. PubMed ID: 9425392 [TBL] [Abstract][Full Text] [Related]
4. Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women. Ongphiphadhanakul B; Puavilai G; Rajatanavin R J Med Assoc Thai; 1996 Sep; 79(9):563-7. PubMed ID: 8996984 [TBL] [Abstract][Full Text] [Related]
5. Bone mineral density in rural Thai adults living in Khon Kaen province. Pongchaiyakul C; Rojroongwasinkul N; Chotmongkol R; Kosulwat V; Charoenkiatkul S; Rajatanavin R J Med Assoc Thai; 2002 Feb; 85(2):235-44. PubMed ID: 12081125 [TBL] [Abstract][Full Text] [Related]
6. Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women. Kung AW; Lorentz T; Tam SC Clin Endocrinol (Oxf); 1993 Nov; 39(5):535-40. PubMed ID: 8252741 [TBL] [Abstract][Full Text] [Related]
7. Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women. Gürlek A; Gedik O Thyroid; 1999 Jun; 9(6):539-43. PubMed ID: 10411115 [TBL] [Abstract][Full Text] [Related]
8. Bone mineral density in postmenopausal women treated with L-thyroxine. Adlin EV; Maurer AH; Marks AD; Channick BJ Am J Med; 1991 Mar; 90(3):360-6. PubMed ID: 2003518 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine. Guo CY; Weetman AP; Eastell R Clin Endocrinol (Oxf); 1997 Mar; 46(3):301-7. PubMed ID: 9156039 [TBL] [Abstract][Full Text] [Related]
10. Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma. Reverter JL; Holgado S; Alonso N; Salinas I; Granada ML; Sanmartí A Endocr Relat Cancer; 2005 Dec; 12(4):973-81. PubMed ID: 16322336 [TBL] [Abstract][Full Text] [Related]
11. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone. Sijanovic S; Karner I Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925 [TBL] [Abstract][Full Text] [Related]
12. Calcaneus as a site for assessment of bone mineral density: evaluation in cadavers and healthy volunteers. Yamada M; Ito M; Hayashi K; Nakamura T AJR Am J Roentgenol; 1993 Sep; 161(3):621-7. PubMed ID: 8352120 [TBL] [Abstract][Full Text] [Related]
13. Appendicular and vertebral bone mass in ankylosing spondylitis. A comparison of plain radiographs with single- and dual-photon absorptiometry and with quantitative computed tomography. Devogelaer JP; Maldague B; Malghem J; Nagant de Deuxchaisnes C Arthritis Rheum; 1992 Sep; 35(9):1062-7. PubMed ID: 1418022 [TBL] [Abstract][Full Text] [Related]
14. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine. Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602 [TBL] [Abstract][Full Text] [Related]
15. Volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in women with differentiated thyroid cancer under TSH suppression. Tournis S; Antoniou JD; Liakou CG; Christodoulou J; Papakitsou E; Galanos A; Makris K; Marketos H; Nikopoulou S; Tzavara I; Triantafyllopoulos IK; Dontas I; Papaioannou N; Lyritis GP; Alevizaki M Clin Endocrinol (Oxf); 2015 Feb; 82(2):197-204. PubMed ID: 25040693 [TBL] [Abstract][Full Text] [Related]
16. Bone mineral density and bone microarchitecture after long-term suppressive levothyroxine treatment of differentiated thyroid carcinoma in young adult patients. Mendonça Monteiro de Barros G; Madeira M; Vieira Neto L; de Paula Paranhos Neto F; Carvalho Mendonça LM; Corrêa Barbosa Lima I; Corbo R; Fleiuss Farias ML J Bone Miner Metab; 2016 Jul; 34(4):417-21. PubMed ID: 26056020 [TBL] [Abstract][Full Text] [Related]
17. Bone mineral density in patients with hyperthyroidism measured by dual energy X-ray absorptiometry. Wakasugi M; Wakao R; Tawata M; Gan N; Koizumi K; Onaya T Clin Endocrinol (Oxf); 1993 Mar; 38(3):283-6. PubMed ID: 8096166 [TBL] [Abstract][Full Text] [Related]
18. Effect of replacement doses of thyroxine on bone mineral density. Hanna FW; Pettit RJ; Ammari F; Evans WD; Sandeman D; Lazarus JH Clin Endocrinol (Oxf); 1998 Feb; 48(2):229-34. PubMed ID: 9579237 [TBL] [Abstract][Full Text] [Related]
19. Bone changes in pre- and postmenopausal women with thyroid cancer on levothyroxine therapy: evolution of axial and appendicular bone mass. Jódar E; Begoña López M; García L; Rigopoulou D; Martínez G; Hawkins F Osteoporos Int; 1998; 8(4):311-6. PubMed ID: 10024900 [TBL] [Abstract][Full Text] [Related]
20. Bone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy. Garton M; Reid I; Loveridge N; Robins S; Murchison L; Beckett G; Reid D Clin Endocrinol (Oxf); 1994 Dec; 41(6):747-55. PubMed ID: 7889610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]